Relay Therapeutics

About:

Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.

Website: http://relaytx.com/

Twitter/X: relay_tx

Top Investors: Google Ventures, Perceptive Advisors, Biotechnology Value Fund, SoftBank Vision Fund, Section 32

Description:

Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.The company's platform detects and characterizes interactions that occur anywhere on a protein and combines computational methods with experimental approaches across the fields of structural biology, biophysics and chemistry, enabling pharmaceutical companies to solve and design therapies against complex diseases like cancer and others.

Total Funding Amount:

$1.4B

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2016-01-01

Contact Email:

info(AT)relaytx.com

Founders:

Alexis Borisy, David E. Shaw, Dorothee Kern, Mark Murcko, Matthew Jacobson

Number of Employees:

251-500

Last Funding Date:

2024-09-10

IPO Status:

Public

© 2025 bioDAO.ai